Orphanet Journal of Rare Diseases (Jan 2020)

Asymptomatic intracranial aneurysms in beta-thalassemia: a three-year follow-up report

  • Renzo Manara,
  • Martina Caiazza,
  • Rosanna Di Concilio,
  • Angela Ciancio,
  • Elisa De Michele,
  • Caterina Maietta,
  • Daniela Capalbo,
  • Camilla Russo,
  • Domenico Roberti,
  • Maddalena Casale,
  • Andrea Elefante,
  • Fabrizio Esposito,
  • Sara Ponticorvo,
  • Andrea Gerardo Russo,
  • Antonietta Canna,
  • Mario Cirillo,
  • Silverio Perrotta,
  • Immacolata Tartaglione

DOI
https://doi.org/10.1186/s13023-020-1302-3
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 4

Abstract

Read online

Abstract Background No information is currently available regarding the natural history of asymptomatic intracranial aneurysms in beta-thalassemia, raising several concerns about their proper management. Methods We performed a prospective longitudinal three-year-long MR-angiography study on nine beta-thalassemia patients (mean-age 40.3 ± 7.5, six females, 8 transfusion dependent) harboring ten asymptomatic intracranial aneurysms. In addition, we analyzed the clinical files of all adult beta-thalassemia patients (160 patients including those followed with MR-angiography, 121 transfusion dependent) referring to our Centers between 2014 and 2019 searching for history of subarachnoid hemorrhage or history of symptomatic intracranial aneurysms. Results At the end of the three-year-long follow-up, no patient showed any change in the size and shape of the aneurysms, none presented new intracranial aneurysms or artery stenoses, none showed new brain vascular-like parenchymal lesions or enlargement of the preexisting ones. Besides, in our database of all adult beta-thalassemia patients, no one had history of subarachnoid hemorrhage or history of symptomatic intracranial aneurysms. Conclusions Incidental asymptomatic intracranial aneurysms do not seem to be associated, in beta-thalassemia, with an increased risk of complications (enlargement or rupture) at least in the short term period, helping to optimize human and economic resources and patient compliance during their complex long-lasting management.

Keywords